New Zealand Pharmaceuticals & Biotech High Insider Buying

Results

0 new

Stocks with high levels of insider buying the past 3 months and good analyst coverage.

2 companies

Pacific Edge

Market Cap: NZ$363.3m

A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.

PEB

NZ$0.31

3.3%

213.1%

Rua Bioscience

Market Cap: NZ$10.1m

Engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally.

RUA

NZ$0.03

7.1%